1046831-97-3

Basic information

• Product Name: 4-BroMo-1-trifluoroMethyl-1H-pyrazole
• Synonyms: 1H-PYRAZOLE, 4-BROMO-1-(TRIFLUOROMETHYL)-
• CAS NO: 1046831-97-3
• Molecular Formula: C₄H₂BrF₃N₂
• Molecular Weight: 214.9712896
• Mol File: 1046831-97-3.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 140.3±40.0 °C(Predicted)
• Appearance: /
• Density: 1.94±0.1 g/cm3(Predicted)
• PKA: -3.99±0.12(Predicted)
• CAS DataBase Reference: 4-BroMo-1-trifluoroMethyl-1H-pyrazole(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BroMo-1-trifluoroMethyl-1H-pyrazole(1046831-97-3)
• EPA Substance Registry System: 4-BroMo-1-trifluoroMethyl-1H-pyrazole(1046831-97-3)

Safety Data

• Hazardous Substances Data: 1046831-97-3(Hazardous Substances Data)

Usage

Uses

4-Bromo-1-(trifluoromethyl)-1H-pyrazole, is a building block used in the synthesis of more complex compounds having therapeutic activities such as anti tumor agents.

Upstream product

• 1046831-96-2 4-bromo-1-(bromodifluoromethyl)-1H-pyrazole 

Downstream Products

• 1046831-98-4 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(trifluoromethyl)-1H-pyrazole 

Relevant articles and documents

7-AZAINDOLE DERIVATIVES AND THEIR USE IN THE INHIBITION OF C-JUN N-TERMINAL KINASE

The present invention provides a compound of formula (I); or a pharmaceutically acceptable salt thereof, the use of a compound of formula (I) or a pharmaceutically acceptable salt thereof in the inhibition of c-Jun N-terminal kinase (JNK) activity and the use in medicine and particularly in the treatment of neurodegenerative disorders, inflammatory diseases and/or and autoimmune diseases. The invention also provides processes for the manufacture of said compounds of formula (I) or a pharmaceutically acceptable salt thereof and compositions containing them